Company profile

Kyowa Kirin

4151 · TSE · Japan

Public Market Listing

4151TSE

TSE primary exchange listing

Live quotes, historical charts, and market capitalization for Kyowa Kirin are available on Yahoo Finance.

View quote & market cap on Yahoo Finance ↗

External market data link · No third-party exchange redistribution

Assets

(5 total)
5Total Assets
1Approved
1Phase 3 / Filed
3Phase 1–2 / Early
5Diseases
Quick filter:
Showing 5 of 5 assets
Target & Modality
istradefylline(Nourianz)
Approved
adenosine A2ASmall molecule
Parkinson's Disease
RTA 402
Phase 3
KEAP1/NRF2Small molecule
Type 2 Diabetes
KK2269
Phase 1
EpCAM (CD326) / CD40Small molecule
Non-Small Cell Lung Cancer
KK2845
Phase 1
TIM-3
Acute Myeloid Leukemia
KK3910
Phase 1
Undisclosed / early pipelineBiologic — subtype unspecified
Hypertension

Upcoming events

Research

Unlock the company readout calendar

Research includes estimated primary-completion dates, earnings report dates, and 'What to watch' trial analysis across this company’s pipeline.

Financial reports

Research

Unlock sourced financial history

Research includes quarterly, interim and annual revenue, R&D, cash and burn figures linked to the underlying company reports.

Educational data tool. Figures are sourced from company filings and press releases: see each row's filing link. Share price is delayed (~15min) and refreshed periodically, not a real-time feed.